Genomtec S.A. (WSE: GMT)
Poland
· Delayed Price · Currency is PLN 7.70
+0.20 (2.67%)
Sep 27, 2024, 5:00 PM CET
Genomtec Market Cap
Genomtec has a market cap or net worth of 102.60 million as of September 30, 2024. Its market cap has decreased by -22.14% in one year.
Market Cap
102.60M
Enterprise Value
97.68M
Revenue
-89.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
7.70
Market Cap Chart
Since March 17, 2021, Genomtec's market cap has decreased from 110.55M to 102.60M, a decrease of -7.19%. That is a compound annual growth rate of -2.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 27, 2024 | 102.60M | -22.86% |
| Dec 29, 2023 | 133.00M | 22.23% |
| Dec 30, 2022 | 108.81M | 42.64% |
| Dec 30, 2021 | 76.28M | -31.00% |
| Mar 17, 2021 | 110.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Krka, d. d. | 17.90B |
| NEUCA S.A. | 3.76B |
| Sopharma AD | 2.17B |
| Synektik Spólka Akcyjna | 1.59B |
| Celon Pharma S.A. | 1.49B |
| Ryvu Therapeutics S.A. | 1.21B |
| Voxel S.A. | 1.13B |
| Selvita S.A. | 1.04B |